Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 40

    1.

    Sodium phosphate tablets and acute phosphate nephropathy.

    Mackey AC, Green L, Amand KS, Avigan M.

    Am J Gastroenterol. 2009 Aug;104(8):1903-6. No abstract available. PMID: 19661931 [PubMed - indexed for MEDLINE]Related articles

    2.

    Finding, evaluating, and managing drug-related risks: approaches taken by the US Food and Drug Administration (FDA).

    Weaver J, Grenade LL, Kwon H, Avigan M.

    Dermatol Ther. 2009 May-Jun;22(3):204-15. Review.PMID: 19453344 [PubMed - indexed for MEDLINE]Related articles

    3.

    Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: update.

    Mackey AC, Green L, Leptak C, Avigan M.

    J Pediatr Gastroenterol Nutr. 2009 Mar;48(3):386-8. No abstract available. PMID: 19274799 [PubMed - indexed for MEDLINE]Related articles

    4.

    Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors.

    Rowan C, Brinker AD, Nourjah P, Chang J, Mosholder A, Barrett JS, Avigan M.

    Pharmacoepidemiol Drug Saf. 2009 Apr;18(4):301-9.PMID: 19206087 [PubMed - indexed for MEDLINE]Related articles

    5.

    Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases.

    Brinker AD, Wassel RT, Lyndly J, Serrano J, Avigan M, Lee WM, Seeff LB.

    Hepatology. 2009 Jan;49(1):250-7.PMID: 19085949 [PubMed - indexed for MEDLINE]Related articles

    6.

    Using controlled clinical trials to learn more about acute drug-induced liver injury.

    Watkins PB, Seligman PJ, Pears JS, Avigan MI, Senior JR.

    Hepatology. 2008 Nov;48(5):1680-9.PMID: 18853438 [PubMed - indexed for MEDLINE]Related articles

    7.

    An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system.

    Colman E, Szarfman A, Wyeth J, Mosholder A, Jillapalli D, Levine J, Avigan M.

    Pharmacoepidemiol Drug Saf. 2008 Nov;17(11):1068-76.PMID: 18821724 [PubMed - indexed for MEDLINE]Related articles

    8.

    Informatic tools and approaches in postmarketing pharmacovigilance used by FDA.

    Weaver J, Willy M, Avigan M.

    AAPS J. 2008;10(1):35-41. Epub 2008 Jan 25. Review.PMID: 18446503 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Brief communication: characteristics of spontaneous cases of tuberculosis associated with infliximab.

    Raval A, Akhavan-Toyserkani G, Brinker A, Avigan M.

    Ann Intern Med. 2007 Nov 20;147(10):699-702.PMID: 18025446 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Indication and use of drug products used to treat attention-deficit/hyperactivity disorder: a cross-sectional study with inference on the likelihood of treatment in adulthood.

    Brinker A, Mosholder A, Schech SD, Burgess M, Avigan M.

    J Child Adolesc Psychopharmacol. 2007 Jun;17(3):328-33.PMID: 17630866 [PubMed - indexed for MEDLINE]Related articles

    11.

    An observational study of cholecystectomy in patients receiving tegaserod.

    Brinker A, Schech SD, Burgess M, Avigan M.

    Drug Saf. 2007;30(7):581-8.PMID: 17604409 [PubMed - indexed for MEDLINE]Related articles

    12.

    U.S. Food and drug administration analysis of strokes associated with raloxifene.

    Wyeth J, Green L, Avigan M.

    Obstet Gynecol. 2007 Apr;109(4):999. No abstract available. PMID: 17400869 [PubMed - indexed for MEDLINE]Related articles

    13.

    Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease.

    Mackey AC, Green L, Liang LC, Dinndorf P, Avigan M.

    J Pediatr Gastroenterol Nutr. 2007 Feb;44(2):265-7.PMID: 17255842 [PubMed - indexed for MEDLINE]Related articles

    14.

    Alosetron: ischemic colitis and serious complications of constipation.

    Gallo-Torres H, Brinker A, Avigan M.

    Am J Gastroenterol. 2006 May;101(5):1080-3.PMID: 16696787 [PubMed - indexed for MEDLINE]Related articles

    15.

    Epidemiology of ischaemic colitis.

    Brinker A, Avigan M.

    Aliment Pharmacol Ther. 2004 Sep 15;20(6):697-8; author reply 698-9. No abstract available. PMID: 15352919 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Re: Brandt et al.--An evidence-based approach to the management of irritable bowel syndrome in North America.

    Avigan M, Justice R, Mackey AC, Nair N.

    Am J Gastroenterol. 2003 Sep;98(9):2105-6. No abstract available. PMID: 14499800 [PubMed - indexed for MEDLINE]Related articles

    17.

    A src-related kinase in the brush border membranes of gastrointestinal cells is regulated by c-met.

    Sunitha I, Shen R, McKillop IH, Lee JH, Resau J, Avigan M.

    Exp Cell Res. 1999 Jul 10;250(1):86-98.PMID: 10388523 [PubMed - indexed for MEDLINE]Related articles

    18.

    FUSE-binding protein is developmentally regulated and is highly expressed in mouse and chicken embryonic brain.

    Wang X, Avigan M, Norgren RB Jr.

    Neurosci Lett. 1998 Aug 21;252(3):191-4.PMID: 9739993 [PubMed - indexed for MEDLINE]Related articles

    19.

    GATA-6 stimulates a cell line-specific activation element in the human lactase promoter.

    Fitzgerald K, Bazar L, Avigan MI.

    Am J Physiol. 1998 Feb;274(2 Pt 1):G314-24.PMID: 9486185 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    A new system for defining endoscopic complications emphasizing the measure of importance.

    Fleischer DE, Van de Mierop F, Eisen GM, al-Kawas FH, Benjamin SB, Lewis JH, Nguyen CC, Avigan M, Tio TL, Kidwell JA.

    Gastrointest Endosc. 1997 Feb;45(2):128-33.PMID: 9040996 [PubMed - indexed for MEDLINE]Related articles

    22.

    High-resolution chromoendoscopy for the diagnosis of diminutive colon polyps: implications for colon cancer screening.

    Axelrad AM, Fleischer DE, Geller AJ, Nguyen CC, Lewis JH, Al-Kawas FH, Avigan MI, Montgomery EA, Benjamin SB.

    Gastroenterology. 1996 Apr;110(4):1253-8.PMID: 8613016 [PubMed - indexed for MEDLINE]Related articles

    23.

    A transactivator of c-myc is coordinately regulated with the proto-oncogene during cellular growth.

    Bazar L, Harris V, Sunitha I, Hartmann D, Avigan M.

    Oncogene. 1995 Jun 1;10(11):2229-38.PMID: 7784068 [PubMed - indexed for MEDLINE]Related articles

    24.

    Targeted melting and binding of a DNA regulatory element by a transactivator of c-myc.

    Bazar L, Meighen D, Harris V, Duncan R, Levens D, Avigan M.

    J Biol Chem. 1995 Apr 7;270(14):8241-8.PMID: 7713931 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    A newly identified tyrosine kinase is preferentially expressed in the gastrointestinal tract.

    Sunitha I, Avigan MI.

    Biochim Biophys Acta. 1994 Apr 28;1221(3):348-52.PMID: 8167158 [PubMed - indexed for MEDLINE]Related articles

    26.

    Hepatocyte growth factor stimulates invasion across reconstituted basement membranes by a new human small intestinal cell line.

    Sunitha I, Meighen DL, Hartman DP, Thompson EW, Byers SW, Avigan MI.

    Clin Exp Metastasis. 1994 Mar;12(2):143-54.PMID: 8306528 [PubMed - indexed for MEDLINE]Related articles

    27.

    A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif.

    Duncan R, Bazar L, Michelotti G, Tomonaga T, Krutzsch H, Avigan M, Levens D.

    Genes Dev. 1994 Feb 15;8(4):465-80.PMID: 8125259 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Specific binding of heterogeneous ribonucleoprotein particle protein K to the human c-myc promoter, in vitro.

    Takimoto M, Tomonaga T, Matunis M, Avigan M, Krutzsch H, Dreyfuss G, Levens D.

    J Biol Chem. 1993 Aug 25;268(24):18249-58.PMID: 8349701 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    A far upstream element stimulates c-myc expression in undifferentiated leukemia cells.

    Avigan MI, Strober B, Levens D.

    J Biol Chem. 1990 Oct 25;265(30):18538-45.PMID: 2211718 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Multifactorial regulation of the human c-myc oncogene.

    Zajac-Kaye M, Avigan M, Takimoto M, Pittaluga S, Quinn J, Gelmann E, Levens D.

    Curr Top Microbiol Immunol. 1988;141:247-52. No abstract available. PMID: 3215053 [PubMed - indexed for MEDLINE]Related articles

    31.

    Delivery of c-myc antisense phosphorothioate oligodeoxynucleotides to hematopoietic cells in culture by liposome fusion: specific reduction in c-myc protein expression correlates with inhibition of cell growth and DNA synthesis.

    Loke SL, Stein C, Zhang X, Avigan M, Cohen J, Neckers LM.

    Curr Top Microbiol Immunol. 1988;141:282-9. No abstract available. PMID: 3063445 [PubMed - indexed for MEDLINE]Related articles

    32.

    Treatment of chronic delta hepatitis with recombinant human alpha interferon.

    Hoofnagle J, Mullen K, Peters M, Avigan M, Park Y, Waggoner J, Gerin J, Hoyer B, Smedile A.

    Prog Clin Biol Res. 1987;234:291-8. No abstract available. PMID: 3628383 [PubMed - indexed for MEDLINE]Related articles

    33.

    Randomized trial of chlorambucil for primary biliary cirrhosis.

    Hoofnagle JH, Davis GL, Schafer DF, Peters M, Avigan MI, Pappas SC, Hanson RG, Minuk GY, Dusheiko GM, Campbell G, et al.

    Gastroenterology. 1986 Dec;91(6):1327-34.PMID: 3533699 [PubMed - indexed for MEDLINE]Related articles

    34.

    The in vitro production of antibodies to mitochondrial antigens by peripheral blood mononuclear cells from patients with primary biliary cirrhosis.

    Avigan MI, Adamson G, Hoofnagle JH, Jones EA.

    Hepatology. 1986 Sep-Oct;6(5):999-1004.PMID: 3758949 [PubMed - indexed for MEDLINE]Related articles

    35.

    A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial.

    Hoofnagle JH, Davis GL, Pappas SC, Hanson RG, Peters M, Avigan MI, Waggoner JG, Jones EA, Seeff LB.

    Ann Intern Med. 1986 Jan;104(1):12-7.PMID: 3940480 [PubMed - indexed for MEDLINE]Related articles

    36.

    Immune effects of alpha-interferon in chronic liver disease.

    Peters M, Walling DM, Waggoner J, Avigan MI, Sjogren M, Hoofnagle JH.

    J Hepatol. 1986;3 Suppl 2:S283-9.PMID: 3598159 [PubMed - indexed for MEDLINE]Related articles

    37.

    Treatment of chronic type B hepatitis with multiple ten-day courses of adenine arabinoside monophosphate.

    Hoofnagle JH, Davis GL, Hanson RG, Pappas SC, Peters MG, Avigan MI, Waggoner JG, Howard R, Jones EA, Straus SE.

    J Med Virol. 1985 Feb;15(2):121-8.PMID: 2579192 [PubMed - indexed for MEDLINE]Related articles

    38.

    Morphologic features of the liver in abetalipoproteinemia.

    Avigan MI, Ishak KG, Gregg RE, Hoofnagle JH.

    Hepatology. 1984 Nov-Dec;4(6):1223-6.PMID: 6500514 [PubMed - indexed for MEDLINE]Related articles

    39.

    Increased T cells lacking immunoglobulin Fc receptors and increased spontaneous morphological blast transformation in a patient with phycomycosis.

    Simon MR, Palutke M, Avigan M, Bradley A.

    J Clin Immunol. 1982 Jan;2(1):59-63.PMID: 6980227 [PubMed - indexed for MEDLINE]Related articles

    40.

    Studies on the compartmentation of lipid in adipose cells. II. Cholesterol accumulation and distribution in adipose tissue components.

    Farkas J, Angel A, Avigan MI.

    J Lipid Res. 1973 May;14(3):344-56.PMID: 9704080 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...